Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2447-2452

  Chen, Liang ^a   Wang, Hui Juan ^b   Xie, Wenli ^a   Yao, Yunyi ^c   Zhang, Yan Shan ^b   Wang, Huiling ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Wuwei Tumor Hospital   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Cryptotanshinone; Lung tumorigenesis; Regulation factor; Tumor inhibition

Indexed keywords

CRYPTOTANSHINONE; DNA; SALVIA MILTIORRHIZA EXTRACT; HERBACEOUS AGENT; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PLANT ROOT; SALVIA MILTIORRHIZA; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BODY WEIGHT; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; GENETICS; LUNG NEOPLASMS; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BODY WEIGHT; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; LUNG NEOPLASMS; MICE; PHENANTHRENES; TUMOR BURDEN; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899682938     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2093     Document Type: Article

References (20)

1. Wang JW and Wu JY: Tanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue cultures. Appl Microbiol Biotechnol 88: 437-449, 2010.
2. Xu M, Cao FL, Li NY, Liu YQ, Li YP and Lv CL: Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells. Asian Pac J Cancer Prev 14: 173-177, 2013.
3. Yuxian X, Feng T, Ren L and Zhengcai L: Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo. Tumori 95: 789-795, 2009.
4. Nizamutdinova IT, Lee GW, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC and Kim HJ: Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. Int J Oncol 33: 485-491, 2008
5. Pan TL, Hung YC, Wang PW, Chen ST, Hsu TK, Sintupisut N, Cheng CS and Lyu PC: Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Proteomics 10: 914-929, 2010
6. Zhang Y, Yao Y, Wang H, Guo Y, Zhang H and Chen L: Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. Chin J Cancer Res 25: 520-526, 2013.
7. Wang X, Morris-Natschke SL and Lee KH: New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27: 133-148, 2007. (Pubitemid 44975189)
8. Ma H, Fan Q, Yu J, Xin J and Zhang C: Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells. Am J Chin Med 41: 197-210, 2013.
9. Heber-Katz E, Zhang Y, Bedelbaeva K, Song F, Chen X and Stocum DL: Cell cycle regulation and regeneration. Curr Top Microbiol Immunol 367: 253-276, 2013.
10. Vleugel M, Hoogendoorn E, Snel B and Kops GJ: Evolution and function of the mitotic checkpoint. Dev Cell 23: 239-250, 2012.
11. Gallorini M, Cataldi A and di Giacomo V: Cyclin-dependent kinase modulators and cancer therapy. BioDrugs 26: 377-391, 2012.
12. Miyazaki T and Arai S: Two distinct controls of mitotic cdk1/cyclin B1 activity requisite for cell growth prior to cell division. Cell Cycle 6: 1419-1425, 2007.
13. Warfel NA and El-Deiry WS: p21WAF1 and tumourigenesis: 20 years after. Curr Opin Oncol 25: 52-58, 2013.
14. Wlodkowic D, Skommer J and Darzynkiewicz Z: Cytometry of apoptosis. Historical perspective and new advances. Exp Oncol 34: 255-262, 2012.
15. Rebucci M and Michiels C: Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 85: 1219-1226, 2013.
16. Barillé-Nion S, Bah N, Véquaud E and Juin P: Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy. Anticancer Res 32: 4225-4233, 2012.
17. Kubli DA and Gustafsson ÅB: Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111: 1208-1221, 2012.
18. Monian P and Jiang X: Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. Exp Oncol 34: 185-191, 2012.
19. Snigdha S, Smith ED, Prieto GA and Cotman CW: Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 28: 14-24, 2012.
20. Cakir E, Yilmaz A, Demirag F, Oguztuzun S, Sahin S, Yazici UE and Aydin M: Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53. APMIS 119: 574-580, 2011.